BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 548819)

  • 1. [Current status of the myocardial depressant factor (MDF) and shock].
    Favaro R; Pelaia P
    Minerva Anestesiol; 1979; 45(7-8):594-600. PubMed ID: 548819
    [No Abstract]   [Full Text] [Related]  

  • 2. Modified paper chromatographic method for assay of myocardial depressant factor.
    Yamada T; Pettit GW
    Circ Shock; 1977; 4(4):379-86. PubMed ID: 598007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of myocardial depressant factor (MDF) during cardiopulmonary bypass (CPB): influence of corticosteroids (methylprednisolone) and protease inhibitor (aprotinin).
    Coraim FI; Laufer G; Ilias W; Wollenek G; Wolner E
    Prog Clin Biol Res; 1987; 236A():611-20. PubMed ID: 2441410
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of the myocardial depressant factor and its relative influence in drug/alcohol mortality.
    Manning TJ; Williams LE; Lynch VD; Bidanset JH; Drake W; Lukash L
    J Forensic Sci; 1980 Jul; 25(3):550-63. PubMed ID: 7400768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of adrenal cortex hormone in endotoxic shock, with special reference to its effect on cardiac function and myocardial depressant factor].
    Kosugi I; Yamaguchi Y; Kawaguchi T; Kawashima Y; Okada K
    Masui; 1976 Feb; 25(2):171-8. PubMed ID: 943602
    [No Abstract]   [Full Text] [Related]  

  • 6. Delayed appearance of a circulating myocardial depressant factor in burn patients.
    De Santis D; Phillips P; Spath MA; Lefer AM
    Ann Emerg Med; 1981 Jan; 10(1):22-4. PubMed ID: 7458026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Humoral factors in cardiogenic shock].
    Kölbel F; Veselý P
    Vnitr Lek; 1978 Jul; 24(7):657-60. PubMed ID: 676122
    [No Abstract]   [Full Text] [Related]  

  • 8. [A low-molecular blood serum factor suppressing myocardial function in traumatic shock complicated by massive blood loss].
    Antonenko VT; Treshchinskiĭ AI; Korolev IuN; Shlapak IP
    Anesteziol Reanimatol; 1988; (5):42-4. PubMed ID: 3218778
    [No Abstract]   [Full Text] [Related]  

  • 9. [The role of the myocardial depressant factor in the pathogenesis of the shock].
    Pagni E
    Minerva Anestesiol; 1980 Sep; 46(9):1001-32. PubMed ID: 7012671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
    Zingarelli B; Squadrito F; Bussolino F; Calapai G; Altavilla D; Ioculano M; Campo GM; Canale P; Caputi AP
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):123-34. PubMed ID: 8012759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts on myocardial depressant factor.
    Giuseppe T; Marco S; Sigfrido I; Pasquale M; Giorgio C
    Mater Med Pol; 1989; 21(1):53-6. PubMed ID: 2699345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Positive modification of hemodynamics in post cardiac surgery patients by hemofiltration. Improved method for the demonstration of myocardial depressant factor (MDF) in hemofiltrate].
    Coraim F; Pauser G; Stellwag F; Werner T; Ziegler W
    Anaesthesist; 1985 May; 34(5):236-40. PubMed ID: 4025793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on low molecular weight inotropic plasma substances in prolonged hypovolemic traumatic shock.
    Hallström S; Vogl C; Krösl P; Redl H; Schlag G
    Prog Clin Biol Res; 1987; 236A():591-7. PubMed ID: 3615453
    [No Abstract]   [Full Text] [Related]  

  • 14. A circulating myocardial depressant substance in septic shock.
    Chest; 1990 Jun; 97(6):1502-3. PubMed ID: 2347245
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myocardial depressant factor in patients with low output syndrome].
    Senoo Y; Mondori E; Nawa S; Kawakami S; Teramoto S
    Kyobu Geka; 1977 Apr; 30(4):313-7. PubMed ID: 559194
    [No Abstract]   [Full Text] [Related]  

  • 16. The pathophysiologic role of myocardial depressant factor as a mediator of circulatory shock.
    Lefer AM
    Klin Wochenschr; 1982 Jul; 60(14):713-6. PubMed ID: 6181287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDF: its participation in the pathophysiology of shock.
    Okada K; Kosugi I; Tanokura Y; Tajimi K; Ohmura A; Innami H; Tsukamoto T; Inaba T
    Prog Clin Biol Res; 1983; 111():125-46. PubMed ID: 6867021
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological modulation of myocardial depressant factor as a mediator of circulatory shock.
    Lefer AM
    J Chemother; 1989 Jul; 1(4 Suppl):469-72. PubMed ID: 16312489
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathophysiology of shock.
    Okada K; Kosugi I; Kitagaki T; Yamaguchi Y; Yoshikawa H
    Jpn Circ J; 1977 Apr; 41(4):346-61. PubMed ID: 875220
    [No Abstract]   [Full Text] [Related]  

  • 20. Salutary effects of anisodamine in murine traumatic shock.
    Hock CE; Su JY; Lefer AM
    Circ Shock; 1983; 11(3):211-6. PubMed ID: 6652878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.